人工胰脏: 现状、挑战与展望

doi:10.3969/j.issn.0258-8021.2013.03.015

Abstract
Figure/Table
References (0)
Related Citation (5)

［1］International Diabetes Federation. IDF diabetes atlas (5th edition) ［EB/OL］. http://www.diabetesatlas.org, 2011-11-14/2012-07-01. 
［2］Clemens AH, Chang PH, Myers RW. The development of Biostator, a glucose controlled insulin infusion system (GCIIS) ［J］. Horm Metab Res Suppl, 1977, 7: 23-33.
［3］Kovatchev B, Anderson S, Heinemann L, et al. Comparison of the numerical and clinical accuracy of four continuous glucose monitors ［J］. Diabetes Care， 2008,　31: 1160-1164.
［4］Zisser H, Robinson L, Bevier W, et al. Bolus calculator: a review of four “smart” insulin pumps ［J］. Diabetes Technol Ther， 2008,　10: 441-444.
［5］Artificial pancreas project ［EB/OL］. http://www.artificialpancreasproject.com, 2005-08-01/2012-03-15. 
［6］Small business innovation research to develop new therapeutics and monitoring technologies for type 1 diabetes (T1D) towards an artificial pancreas ［EB/OL］. http://grants.nih.gov/grants/guide/rfafiles/RFADK09001.html, 2008-12-10/2012-03-15. 
［7］Artificial pancreas (AP) at home ［EB/OL］. http://www.apathome.eu, 2010-02-01/2012-07-01. 
［8］Zhou J, Li H, Ran XW, et al. Reference values for continuous glucose monitoring in Chinese subjects ［J］. Diabetes Care， 2009,　32: 1188-1193.
［9］Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China ［J］. The New England Journal of Medicine， 2012, 362: 1090-1101.
［10］姜利英, 任丽洁, 陈青华, 等. 血糖检测技术研究进展［J］. 传感器世界， 2009,　10: 6-10, 31.
［11］Ho H, Saeedi E, Kim SS, et al. Contact lens with integrated inorganic semiconductor devices ［C］ // 21st IEEE International Conference on MicroElectroMechanical Systems (MEMS). Tucson, Arizona, 2008: 403-406.
［12］Garg SK, Smith J, Beatson C, et al. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems ［J］. Diabetes Technology & Therapeutics， 2009,　11(2): 65-72.
［13］Kamath A, Mahalingam A, Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor ［J］. Diabetes Technol Ther， 2009,　11: 689–695.
［14］Garg SK, Voelmle M, Gottlieb PA. Time lag characterization of two continuous glucose monitoring systems ［J］. Diabetes Res Clin Pract， 2010,　87: 348-353.
［15］Keenan DB, Mastrototaro JJ, Voskanyan G, et al. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology ［J］. J Diabetes Sci Technol， 2009, 3: 1207–1214.
［16］Jakisch BI, Wagner VM, Heidtmann B, et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric type 1 diabetes: a multicentre matchedpair cohort analysis over 3 years ［J］. Diabetic Medicine， 2008,　25: 80-85.
［17］Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy ［J］. Diabetes Meta Res Rev， 2009,　25: 99-111.
［18］Steiner S, Hompesch M, Pohl R, et al. A novel insulin formulation with a more rapid onset of action ［J］. Diabetologia， 2008,　51: 1602-1606.
［19］Bequette BW. A critical assessment of algorithms and challenges in the development of a closedloop artificial pancreas ［J］. Diabetes Technol Ther， 2005,　7: 28-47.
［20］Parker RS, Doyle III FJ, Peppas NA. A modelbased algorithm for blood glucose control in type I diabetic patients ［J］. IEEE Trans Biomed Eng， 1999,　46: 148-157.
［21］Hovorka R, Canonico V, Chassin LJ, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes ［J］. Physiol Meas， 2004,　25(4): 905-920.
［22］Wang Y, Zisser H, Dassau E, et al. Model predictive control with learningtype setpoint: application to artificial pancreatic betacell ［J］. AIChE J， 2010,　56: 1510-1518.
［23］Marchetti G, Barolo M, Jovanovi?倣 L, et al. An improved PID switching control strategy for type 1 diabetes ［J］. IEEE T Biomed Eng， 2008,　55: 857-865.
［24］Clemens AH. Feedback control dynamics for glucose controlled insulin infusion system ［J］. Med Prog Technol， 1979,　6: 91-98.
［25］Atlas E, Nimri R, Miller S, et al. MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes ［J］. Diabetes Care， 2010,　33: 1072-1076.
［26］Mauseth R, Wang Y, Dassau E, et al. Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor ［J］. J Diabetes Sci Technol， 2010,　4(4): 913-922.
［27］ElKhatib FH, Jiang J, Damiano ER. Adaptive closedloop control provides bloodglucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine ［J］. J Diabetes Sci Technol， 2007,　1: 181-192.
［28］RodríguezHerrero A, PérezGandía C, Rigla M, et al. A simulation study of an inverse controller for closed and semiclosedloop control in type 1 diabetes ［J］. Diabetes Technol Ther， 2010,　12(2): 95-104.
［29］Wang Y, Dassau E, Zisser H, et al. Automatic bolus and adaptive basal (ABAB) algorithm for the artificial pancreatic βcell ［J］. Diabetes Technol & Ther， 2010: (in press).
［30］Kiam Heong A, Chong G, Yun L. PID control system analysis, design, and technology ［J］. Control Systems Technology, IEEE Transactions on， 2005,　13(4): 559-576.
［31］Ellingsen C, Dassau E, Zisser H, et al. Safety constraints in an artificial pancreatic beta cell: an implementation of model predictive control with insulin on board ［J］. J Diabetes Sci Technol， 2009,　3(3): 536-544.
［32］Hovorka R, Allen JM, Elleri D, et al. Manual closedloop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial ［J］. The Lancet， 2010,　375: 743-751.
［33］Buckingham B, Cobry E, Clinton P, et al. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension ［J］. Diabetes Technol Ther， 2009,　11: 93-97.
［34］王友清, 脱建勇. 网络丢包时“人工胰脏”的可靠控制［J］. 南京航空航天大学学报， 2011,　43(S): 194-198.
［35］Dalla Man C, Breton MD, Cobelli C. Physical activity into the meal glucoseinsulin model of type 1 diabetes: in silico studies ［J］. J Diabetes Sci Technol， 2009,　3: 56-67.
［36］Kovatchev BP, Breton M, Dalla Man C, et al. In silico preclinical trials: a proof of concept in closedloop control of type 1 diabetes ［J］. J Diabetes Sci Technol， 2009,　3: 44-55.
［37］Wilinska ME, Chassin LJ, Acerini CL, et al. Simulation environment to evaluate closedloop insulin delivery systems in type 1 diabetes ［J］. J Diabetes Sci Technol， 2010,　4(1): 132-144.
［38］ZlKhatib FH, Russell SJ, Nathan DM, et al. A bihormonal closedloop artificial pancreas for type 1 diabetes. ［J］. Sci Transl Med， 2010,　2: 27ra27.
［39］Dassau E, Zisser H, Palerm CC, et al. Modular artificial betacell system: a prototype for clinical research ［J］. J Diabetes Sci Technol， 2008,　2(5): 863-872.
［40］Raymond, N. Artificial pancreas a realworld success ［EB/OL］. http://www.medicine.virginia.edu/research/institutesandprograms/cdt/artificalpancreastechnology, 2011-11-21/2012-07-01. 
［41］Elleri D, Dunger DB, Hovorka R. Closedloop insulin delivery for treatment of type 1 diabetes ［J］. BMC Medicine， 2011,　9: 120-128.
［42］Buckingham B, Chase HP, Dassau E, et al. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension ［J］. Diabetes Care， 2010,　33: 1013-1017.
［43］Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk ［J］. Diabetes Care， 2011,　34: 2023-2025.
［44］Danne T, Kordonouri O, Holder M, et al. Prevention of hypoglycemia by using low glucose suspend function in sensoraugmented pump therapy ［J］. Diabetes Technol Ther， 2011,　13: 1-6.
［45］Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies ［J］. BMJ， 2011,　342: d1855.
［46］Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control ［J］. J Clin Endocrinol Metab， 2011,　96: 1402-1408.
［47］Murphy HR, Elleri D, Allen JM, et al. Closedloop insulin delivery during pregnancy complicated by type 1 diabetes ［J］. Diabetes Care， 2011,　34: 406-411.
［48］Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24 h closedloop insulin delivery in wellcontrolled pregnant women with type 1 diabetes: a randomized crossover case series ［J］. Diabetes Care， 2011,　34(12): 2527-2529.
［49］Liebl A, Hoogma R, Renard E, et al. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion ［J］. Diabetes Obes Metab， 2009,　11(1001-1008).
［50］Kovatchev B, Cobelli C, Renard E, et al. Multinational study of subcutaneous modelpredictive closedloop control in type 1 diabetes mellitus: summary of the results ［J］. J Diabetes Sci Technol， 2010,　4: 1374-1381.
［51］Weinzimer SA, Steil GM, Swan KL, et al. Fully automated closedloop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas ［J］. Diabetes Care， May 2008 2008,　31(5): 934-939.
［52］Steil GM, Rebrin K, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes ［J］. Diabetes， 2006,　55(12): 3344-3350.
［53］Castle JR, Engle JM, El YJ, et al. Novel use of glucagon in a closedloop system for prevention of hypoglycemia in type 1 diabetes ［J］. Diabetes Care， 2010,　33: 1282-1287.
［54］ElKhatib FH, Jiang J, Damiano ER. A feasibility study of bihormonal closedloop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine ［J］. J Diabetes Science and Technology， 2009,　3: 789-803.
［55］Microsoft Research Connections Team. Functional lens promises to improve the quality of life for diabetics and others ［EB/OL］. http://blogs.msdn.com/b/msr_er/archive/2011/07/27/functionallenspromisestoimprovethequalityoflifefordiabeticsandothers.aspx, 2011-07-27/2012-07-01. 
［56］Schaepelynck P, Darmon P, Molines L, et al. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps ［J］. Diabetes Metab， Dec 2011,　37: S85-S93.
［57］Vaughn DE, Yocum RC, Muchmore DB, et al. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase ［J］. Diabetes Technology & Therapeutics， Jun 2009,　11(6): 345-352.
［58］Steiner S, Hompesch M, Pohl R, et al. A novel insulin formulation with a more rapid onset of action ［J］. Diabetologia， Sep 2008,　51(9): 1602-1606.
［59］Raz I, Weiss R, Yegorchikov Y, et al. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an openlabel, randomized, twoperiod, oneway crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion ［J］. Clin Ther， 2009,　31(5): 980-987.
［60］Pettis RJ, Ginsberg B, Hirsch L, et al. Intradermal microneedle delivery of insulin Lispro achieves faster insulin absorption and insulin action than subcutaneous injection ［J］. Diabetes Technology & Therapeutics， Apr 2011,　13(4): 435-442.
［61］Cobelli C, Dalla Man C, Sparacino G, et al. Diabetes: models, signals, and control ［J］. IEEE Reviews in Biomedical Engineering， 2009,　2: 54-96.
［62］Harvey RA, Wang Y, Grosman B, et al. Quest for the artificial pancreas: combining technology with treatment ［J］. IEEE Engineering in Medicine and Biology Magazine， 2010,　29: 53-62 
［63］Wang Y, Dassau E, Doyle III FJ. Closedloop control of artificial pancreatic betacell in type 1 diabetes mellitus using model predictive iterative learning control ［J］. IEEE T Biomedical Engineering， 2010,　57: 211-219.
［64］Tsalikian E, Mauras N, Beck RW, et al. Impact of exercise on overnight glycemic control in  children with type 1 diabetes mellitus ［J］. Journal of Pediatrics， 2005,　147(4): 528-534.
［65］Bussau VA, Ferreira LD, Jones TW, et al. A 10s sprint performed prior to moderateintensity exercise prevents early postexercise fall in glycaemia in individuals with type 1 diabetes ［J］. Diabetologia， 2007,　50(9): 18151818.
［66］Breton MD. Physical activity—the major unaccounted impediment to closed loop control ［J］. J Diabetes Sci Technol， 2008,　2: 169-174.